| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
1 Harvard-Partners Center for Genetics and Genomics and 2 Rodent Histopathology Core, Harvard Medical School; 3 Department of Pathology, Tufts University Schools of Medicine and Veterinary Medicine, Boston, Massachusetts
Requests for reprints: Melanie H. Kucherlapati, Harvard-Partners Center for Genetics and Genomics, Harvard Medical School, 77 Avenue Louis Pasteur, New Research Building 160B, Boston, MA 02115. Phone: 617-525-4438; Fax: 617-525-4435; E-mail: mkucherlapati{at}rics.bwh.harvard.edu.
We have crossed mice carrying the conditional Rbtm2Brn allele with a constitutive Villin-Cre transgenic mouse. The Villin promoter in these animals is highly expressed in adult intestine and kidney proximal tubules and is expressed in the gut and nephros anlagen during embryogenesis. We report here that these mice develop tumors between 12 and 17 months old outside the gastrointestinal (GI) tract. A high penetrance of pituitary tumors and medullar carcinoma of the thyroid is observed with a lower incidence of hyperplasia of pulmonary neuroendocrine cells and aggressive liver, bile duct, stomach, oral cavity tumors, and lipomas. Rb rearrangement due to ectopic Villin promoter activity in neural crest or neural crest stem cells during embryogenesis is most likely responsible for the medullar carcinoma of the thyroid phenotype. The aggressive nature of the medullar carcinoma of the thyroid and its ability to metastasize to unusual sites make the model suitable for the study of tumor progression and mechanism of metastasis. Observed sites of metastasis include the stomach, small intestine, liver, lung, kidney, pancreas, spleen, bone marrow, salivary gland, fat, lymph nodes, and dorsal root ganglion. Because the Villin promoter is highly active throughout the GI and in the nephros anlagen during development, we find that Rb inactivation is not sufficient to initiate tumorigenesis in the GI or kidneys in mice. (Cancer Res 2006; 66(7): 3576-83)
This article has been cited by other articles:
![]() |
A. Cerrato, V. De Falco, and M. Santoro Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets J. Mol. Endocrinol., October 1, 2009; 43(4): 143 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Guo, S. Longshore, R. Nair, and B. W. Warner Retinoblastoma Protein (pRb), but Not p107 or p130, Is Required for Maintenance of Enterocyte Quiescence and Differentiation in Small Intestine J. Biol. Chem., January 2, 2009; 284(1): 134 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Kucherlapati, K. Yang, K. Fan, M. Kuraguchi, D. Sonkin, A. Rosulek, M. Lipkin, R. T. Bronson, B. J. Aronow, and R. Kucherlapati Loss of Rb1 in the gastrointestinal tract of Apc1638N mice promotes tumors of the cecum and proximal colon PNAS, October 7, 2008; 105(40): 15493 - 15498. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Mason-Richie, M. J. Mistry, C. A. Gettler, A. Elayyadi, and K. A. Wikenheiser-Brokamp Retinoblastoma Function Is Essential for Establishing Lung Epithelial Quiescence after Injury Cancer Res., June 1, 2008; 68(11): 4068 - 4076. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Saenz-Robles, J. A. Markovics, J.-L. Chong, R. Opavsky, R. H. Whitehead, G. Leone, and J. M. Pipas Intestinal Hyperplasia Induced by Simian Virus 40 Large Tumor Antigen Requires E2F2 J. Virol., December 1, 2007; 81(23): 13191 - 13199. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |